Urinary albumin excretion in a population based sample of 1011 middle aged non-diabetic subjects

References

• Waller K V., Ward K M., Mahan J D., Wismatt D K. Current concepts in proteinuria. Clin Chem 1989; 35: 755–65
   PubMed Web of Science ®Google Scholar
• Feldt-Rasmussen B, Mathiesen E R. Variability of urinary albumin excretion in incipient diabetic nephropathy. Diab Nephrop 1984; 3: 101–3
   Google Scholar
• Mogensen C E., Chachati A, Christensen C K., et al. Microalbuminuria, an early marker of renale involvement in diabetes. Uremia Invest 1986; 9(2)85–95
   Google Scholar
• Viberti G C., Hill R D., Jarret R J., Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982; i: 1430–2
   Google Scholar
• Mogensen C E. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1986; 310: 356–60
   Web of Science ®Google Scholar
• Messent J WC, Elliot T G., Hill R D., Jarret R J., Keen H, Viberti G C. Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: A twenty-three year follow-up study. Kidney Int 1992; 41: 836–9
   PubMed Web of Science ®Google Scholar
• Schmitz A, Vaeth M. Microalbuminuria: A major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diab Med 1988; 5: 1126–34
   Google Scholar
• Parving H-H, Hommel E, Mathiesen E R., et al. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in insulin-dependent diabetic patients. Br Med J 1988; 296: 156–60
   PubMed Web of Science ®Google Scholar
• Gall M-A, Rossing P, Skott P, et al. Prevalence of micro- and macroaluminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991; 34: 655–61
   PubMed Web of Science ®Google Scholar
• Metcalf P, Baker J, Scott A, Wild C, Scragg R, Dryson E. Albuminuria in people at least 40 years old: Effect of obesity, hypertension and hyper-lipidemia. Clin Chem 1992; 38: 1802–8
   PubMed Web of Science ®Google Scholar
• Winocour P H., Harland J OE, Millar J P., Laker M F., Alberti K GMM. Microalbuminuria and associated cardiovascular risk factors in the community. Atherosclerosis 1992; 93: 71–81
   PubMedGoogle Scholar
• Haffner S M., Stern M O., Gruber M KK, Hazuda H P., Mitchell B D., Patterson J K. Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects? Arteriosclerosis 1990; 10: 727–31
   Google Scholar
• Yudkin J S., Forrest R D., Jackson C A. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet 1988; ii: 530–3
   Google Scholar
• Damsgaard E M., Freland A, Jergensen O D., Mogensen C E. Microalbuminuria as predictor of increased mortality in elderly people. Br Med J 1990; 300: 297–300
   PubMed Web of Science ®Google Scholar
• Damsgaard E M., Freland A, Jergensen O D., Mogensen C E. Eight to nine year mortality in known non-insulin-dependent diabetics and controls. Kidney Int 1992; 41: 731–5
   PubMedGoogle Scholar
• The Copenhagen City Heart Study Group. The Copenhagen City Heart Study. A book of tables with data from the first examination (1976-78) and a five year follow-up (1981–83). Scand J Soc Med 1989; 170(suppl 41)1–160
   Google Scholar
• Jensen G. Epidemiology of chest pain and angina pectoris–with special reference to treatment needs. Acta Med Scand 1983; 214(suppl 682)1–120
   Google Scholar
• Rose G A. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull Wld Hlth Org 1962; 27: 546–58
   Google Scholar
• Feldt-Rasmussen B, Dinesen B, Deckert M. Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest 1985; 45: 539–44
   PubMed Web of Science ®Google Scholar
• Esbjaj O, Feldt-Rasmussen B, Larsen M L., Mogensen E F. Comparison of overnight, morning and 24 h urine collections in assessment of diabetic microalbuminuria. Diab Med 1987; 4: 531–3
   PubMedGoogle Scholar
• Bohn L. Evaluation of some qualitative and quantitative tests for proteinuria. Dan Med Bull 1973; 20: 25–9
   PubMed Web of Science ®Google Scholar
• Hemmingsen L, Skaarup P. The 24-h excretion of plasma proteins in the urine of apparently healthy subjects. Scand J Clin Lab Invest 1975; 35: 347–53
   PubMed Web of Science ®Google Scholar
• Watts G F., Morris R W., Khan K, Polak A. Urinary albumin excretion in healthy adult subjects: refer-ernce values and some factors affecting their interpretation. Clin Chim Acta 1988; 172: 191–8
   PubMedGoogle Scholar
• Nyboe J, Jensen G, Appleyard M, Schnohr P. Risk factors for acute myocardial infarction in Copenhagen. I: Hereditary, educational and socioeconomic factors. Eur Heart J 1989; 10: 910–6
   PubMed Web of Science ®Google Scholar
• Boysen G, Nyboe J, Appleyard M, et al. Stroke incidence and risk factors for stroke in Copenhagen, Denmark. Stroke 1988; 19: 1345–53
   PubMed Web of Science ®Google Scholar
• Levey A S., Madaio M P., Perrone R D. Laboratory assessment of renal disease: clearance, urinalysis and renal biopsy. The Kidney,4th edn., B Brenner. Saunders, Philadelphia 1991; 919–50
   Google Scholar
• Parving H-H, Jensen H M., Mogensen C E., Evrin P-E. Increased urinary albumin-excretion rate in benign essential hypertension. Lancet 1974; i: 1190–2
   Google Scholar
• Ljungman S. Microalbuminuria in essential hypertension. Am J Hypertens 1990; 3: 956–60
   PubMed Web of Science ®Google Scholar
• Ross R. The pathogenesis of atherosclerosis–an update. N Engl J Med 1986; 314: 488–500
   PubMed Web of Science ®Google Scholar